Value Blog

It’s Time to Think Seriously About Our Democracy

September 7th, 2016  |  Source: PS Magazine

Recent developments, like the rise of Donald Trump, suggest that we shouldn’t take our beloved democratic systems for granted.


Economist calls the S&P 500’s new 11th sector a boondoggle

September 6th, 2016  |  Source:

Real estate will become the S&P 500’s 11th sector next month. Market historian and money manager Laszlo Birinyi isn’t applauding.

Birinyi, in a Monday note, characterized the move as aimed more “to the benefit of the vendor and not the customer.”


August 30th, 2016  |  Source:

The marijuana industry has clearly reached a new level of mass commercialism and I fear we’re in danger of creating a “Marijuana Industrial Complex” that involves venture capitalists, Wall Street traders, pharmaceutical companies, celebrity branding, government regulation and even mainstream media catering to the marijuana industry.

How the Money Bail System Perpetuates America’s Mass Incarceration Problem

August 26th, 2016  |  Source: PS Magazine

If there was ever an example of how economic incentives can warp the institutions of justice, local jails are it.

At this very moment, nearly 450,000 Americans are sitting in county jails not because they’ve been charged with a crime, but because they simply don’t have enough money to post bail. And according to a new study, America’s money bail system isn’t just unconstitutional—it’s a fundamental engine of injustice in the United States.

Mylan offers discounts on EpiPen after Clinton criticism

August 25th, 2016  |  Source: Reuters

Mylan NV (MYL.O) said on Thursday it would reduce the out-of-pocket cost of its severe allergy treatment EpiPen through a discount program, a day after Democratic Presidential candidate Hillary Clinton joined lawmakers in criticizing the drug's high price.

The company, which did not lower the drug's list price, said it would reduce the patient cost of EpiPen through the use of a savings card, which will cover up to $300 of EpiPen 2-Pak.


Why Big Pharma’s Argument for Its High Drug Prices Doesn’t Make Sense

August 24th, 2016  |  Source: PS Magazine

America is only middle-of-the-road when it comes to innovation for dollar spent.

Drug pricing in America has gained a lot of attention recently, with the price tags of everything from new cancer medicines to EpiPens skyrocketing. Many have wondered: Is it fair to make life-saving drugs so costly?

The Internet of Poorly Working Things

August 23rd, 2016  |  Source: Monday Note

In the mythical Land of Theory, where everything ‘just works’, we can connect all the objects in our lives. We have the sensors, the wireless networks, and the computing power, but progress is slow if not comically wrong. Why?


Aetna, Obamacare and health insurers’ 10 dirty secrets

August 19th, 2016  |  Source:

Health insurers have an incentive to enrich shareholders and deny coverage to customers

Whom do U.S. health insurers think they’re kidding?

The answer, of course, is: everybody.

About Value News Network

Value is the only commonality in an increasingly complex, challenging and interdependent world.
Laurance Allen: Editor + Publisher

Connect with Us